Stock IMMB IMMUNOTECH LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Immunotech Laboratories, Inc.

Equities

IMMB

US45254F2039

Market Closed - OTC Markets
Other stock markets
 02:01:22 2024-03-18 pm EDT 		5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Immunotech Laboratories, Inc. -.--% -.--%
2017 Immunotech Laboratories, Inc. Announces Addition of Hongxiang Hui to Advisory Board CI
2017 Immunotech Laboratories Enters Distribution Agreement for the Territory of the Ukraine; Enters Final Step of Full Commercialization by the BDA Post Phase 3 Approval of ITV-1 for HIV/AIDS CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Immunotech Laboratories, Inc. Announces Addition of Hongxiang Hui to Advisory Board
CI
Immunotech Laboratories Enters Distribution Agreement for the Territory of the Ukraine; Enters Final Step of Full Commercialization by the BDA Post Phase 3 Approval of ITV-1 for HIV/AIDS
CI
Eco-Petroleum Solutions, Inc. acquired Immunotech Laboratories, Inc..
CI
Immunotech Laboratories, Inc. cancelled the transaction announced on October 1, 2013
CI
Ebola becomes latest stock scam, SEC says
RE
Immunotech Laboratories, Inc. and Immunotech Laboratories, BG Enter into Agreement with Uldic Investment to Market Potential Ebola Virus Disease Treatment in Africa
CI
Immunotech Laboratories, Inc and Immunotech Laboratories, BG. Announces Successful Completion of Phase I and Phase II Field Trials of HIV/AIDS and Hepatitis C Virus Treatment
CI
Immunotech Laboratories, Inc. Announces Completion of Phase I and Phase II Field Trials of Patented Treatment of the HIV/AIDS and Hepatitis C Viruses
CI
Immunotech Laboratories, Inc. announced that it expects to receive funding from World Finance Capital Holdings Inc.
CI
Immunotech Laboratories, Inc. Appoints Blaine Nabors as VP of Business Development
CI
Immunotech Laboratories, Inc. Relocates to New Research & Development Laboratory Facility
CI
Immunotech Laboratories, Inc. Announces Clinical Trials Updates for company's AIDS-HIV 'IPF' Medicines
CI
Immunotech Laboratories, Inc. Appoints Valentin Dimitrov to Board of Directors
CI
Immunotech Laboratories, Inc. Appoints Bo Linton as Director
CI
Immunotech Laboratories, Inc. Announces Resignation of Ara Ghanime as Director
CI
IMMUNOTECH LABORAT : Immunotech Completes Merger Acquisition
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMMB Stock
  4. News Immunotech Laboratories, Inc.